EXICURE, INC. (XCUR)
US Markets · Healthcare · Biotechnology
$2.99
+2.40%
Closing price as of 2026-06-08 · Source: TEK2day Finance
Key Metrics
Market Cap
$17.0M
About EXICURE, INC.
Exicure, Inc. does not have significant operations. Previously, it focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The company has a co-development agreement with Adbiotech Co., Ltd. to explore combination therapies based on Burixafor (GPC-100) across multiple therapeutic areas. Exicure, Inc. was founded in 2011 and is headquartered in Redwood City, California.